259 related articles for article (PubMed ID: 37799331)
1. Exploring the leishmanicidal potential of terpenoids: a comprehensive review on mechanisms of cell death.
Rodrigues ACJ; Carloto ACM; Gonçalves MD; Concato VM; Detoni MB; Dos Santos YM; Cruz EMS; Madureira MB; Nunes AP; Pires MFMK; Santos NC; Marques REDS; Bidoia DL; Borges Figueiredo F; Pavanelli WR
Front Cell Infect Microbiol; 2023; 13():1260448. PubMed ID: 37799331
[TBL] [Abstract][Full Text] [Related]
2. Potential of the natural products against leishmaniasis in Old World - a review of in-vitro studies.
Cortes S; Bruno de Sousa C; Morais T; Lago J; Campino L
Pathog Glob Health; 2020 May; 114(4):170-182. PubMed ID: 32339079
[TBL] [Abstract][Full Text] [Related]
3. Recent researches in effective antileishmanial herbal compounds: narrative review.
Ghodsian S; Taghipour N; Deravi N; Behniafar H; Lasjerdi Z
Parasitol Res; 2020 Dec; 119(12):3929-3946. PubMed ID: 32803335
[TBL] [Abstract][Full Text] [Related]
4. Natural products derived steroids as potential anti-leishmanial agents; disease prevalence, underlying mechanisms and future perspectives.
Elawad MA; Elkhalifa MEM; Hamdoon AAE; Salim LHM; Ahmad Z; Ayaz M
Steroids; 2023 May; 193():109196. PubMed ID: 36764565
[TBL] [Abstract][Full Text] [Related]
5. Exploration of Antileishmanial Compounds Derived from Natural Sources.
Peer GDG; Priyadarshini A; Gupta A; Vibhuti A; Raj VS; Chang CM; Pandey RP
Antiinflamm Antiallergy Agents Med Chem; 2024; 23(1):1-13. PubMed ID: 38279725
[TBL] [Abstract][Full Text] [Related]
6. Anti-Leishmania amazonensis activity of the terpenoid fraction from Eugenia pruniformis leaves.
Albuquerque RDDG; Oliveira AP; Ferreira C; Passos CLA; Fialho E; Soares DC; Amaral VF; Bezerra GB; Esteves RS; Santos MG; Albert ALM; Rocha L
An Acad Bras Cienc; 2020; 92(4):e20201181. PubMed ID: 33295583
[TBL] [Abstract][Full Text] [Related]
7. Plant natural products with leishmanicidal activity.
Chan-Bacab MJ; Peña-Rodríguez LM
Nat Prod Rep; 2001 Dec; 18(6):674-88. PubMed ID: 11820764
[No Abstract] [Full Text] [Related]
8. Evaluation of target-specific natural compounds for drug discovery against Leishmaniasis.
Gouri V; Upreti S; Samant M
Parasitol Int; 2022 Dec; 91():102622. PubMed ID: 35798284
[TBL] [Abstract][Full Text] [Related]
9. Promising natural products for the treatment of cutaneous leishmaniasis: A review of in vitro and in vivo studies.
Afonso RC; Yien RMK; de Siqueira LBO; Simas NK; Dos Santos Matos AP; Ricci-Júnior E
Exp Parasitol; 2023 Aug; 251():108554. PubMed ID: 37268108
[TBL] [Abstract][Full Text] [Related]
10. Laurequinone, a Lead Compound against
García-Davis S; López-Arencibia A; Bethencourt-Estrella CJ; San Nicolás-Hernández D; Viveros-Valdez E; Díaz-Marrero AR; Fernández JJ; Lorenzo-Morales J; Piñero JE
Mar Drugs; 2023 May; 21(6):. PubMed ID: 37367658
[TBL] [Abstract][Full Text] [Related]
11. Plants as Antileishmanial Agents: Current Scenario.
Ullah N; Nadhman A; Siddiq S; Mehwish S; Islam A; Jafri L; Hamayun M
Phytother Res; 2016 Dec; 30(12):1905-1925. PubMed ID: 27704633
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of lapachol on treatment of cutaneous and visceral leishmaniasis.
Araújo IAC; de Paula RC; Alves CL; Faria KF; Oliveira MM; Mendes GG; Dias EMFA; Ribeiro RR; Oliveira AB; Silva SMD
Exp Parasitol; 2019 Apr; 199():67-73. PubMed ID: 30797783
[TBL] [Abstract][Full Text] [Related]
13. Modes of action of Leishmanicidal antimicrobial peptides.
Marr AK; McGwire BS; McMaster WR
Future Microbiol; 2012 Sep; 7(9):1047-59. PubMed ID: 22953706
[TBL] [Abstract][Full Text] [Related]
14. High-throughput screening platform for natural product-based drug discovery against 3 neglected tropical diseases: human African trypanosomiasis, leishmaniasis, and Chagas disease.
Annang F; Pérez-Moreno G; García-Hernández R; Cordon-Obras C; Martín J; Tormo JR; Rodríguez L; de Pedro N; Gómez-Pérez V; Valente M; Reyes F; Genilloud O; Vicente F; Castanys S; Ruiz-Pérez LM; Navarro M; Gamarro F; González-Pacanowska D
J Biomol Screen; 2015 Jan; 20(1):82-91. PubMed ID: 25332350
[TBL] [Abstract][Full Text] [Related]
15. Limitations of Current Therapeutic Options, Possible Drug Targets and Scope of Natural Products in Control of Leishmaniasis.
Tiwari N; Gedda MR; Tiwari VK; Singh SP; Singh RK
Mini Rev Med Chem; 2018; 18(1):26-41. PubMed ID: 28443518
[TBL] [Abstract][Full Text] [Related]
16. Exploring Innovative Leishmaniasis Treatment: Drug Targets from Pre-Clinical to Clinical Findings.
Santana W; de Oliveira SSC; Ramos MH; Santos ALS; Dolabella SS; Souto EB; Severino P; Jain S
Chem Biodivers; 2021 Sep; 18(9):e2100336. PubMed ID: 34369662
[TBL] [Abstract][Full Text] [Related]
17. The anti-Leishmania potential of bioactive compounds derived from naphthoquinones and their possible applications. A systematic review of animal studies.
Ramos-Milaré ÁCFH; Oyama J; Murase LS; Souza JVP; Guedes BS; Lera-Nonose DSSL; Monich MT; Brustolin AÁ; Demarchi IG; Teixeira JJV; Lonardoni MVC
Parasitol Res; 2022 May; 121(5):1247-1280. PubMed ID: 35190878
[TBL] [Abstract][Full Text] [Related]
18. Nanomedicine in leishmaniasis: A promising tool for diagnosis, treatment and prevention of disease - An update overview.
Assolini JP; Carloto ACM; Bortoleti BTDS; Gonçalves MD; Tomiotto Pellissier F; Feuser PE; Cordeiro AP; Hermes de Araújo PH; Sayer C; Miranda Sapla MM; Pavanelli WR
Eur J Pharmacol; 2022 May; 923():174934. PubMed ID: 35367420
[TBL] [Abstract][Full Text] [Related]
19. Immunomodulation by chemotherapeutic agents against Leishmaniasis.
Saha P; Mukhopadhyay D; Chatterjee M
Int Immunopharmacol; 2011 Nov; 11(11):1668-79. PubMed ID: 21875692
[TBL] [Abstract][Full Text] [Related]
20. Imaging host-Leishmania interactions: significance in visceral leishmaniasis.
Forestier CL
Parasite Immunol; 2013; 35(9-10):256-66. PubMed ID: 23772814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
